A clear look at the 340B program: how hospitals generate revenue from drug discounts, why it has expanded, and the growing ...
Following Eli Lilly and Johnson & Johnson, Sanofi is aiming to change how it participates in the 340B program, a federal drug pricing program created in 1992, The Wall Street Journal reported Nov. 22.
The Health Resources and Services Administration ("HRSA") plans to implement a limited pilot program that will allow approved manufacturers to issue post-purchase rebates for 340B covered outpatient ...
AbbVie looks to "restore integrity" to the 340B program with its suit, it explained in its 72-page filing. (iStock / Getty Images Plus) AbbVie is spearheading a new battle in pharma’s long-running ...
A recent congressional hearing on 340B is the latest iteration of a standoff between two pillars of the healthcare industry—hospitals and pharmaceutical manufacturers—both of which have powerful ...
The program was meant to help hospitals provide for poor patients by offering drug savings. But critics say a Texas company has turned it into a big business, driving up costs for patients and ...
On July 31, 2025, the Health Resources and Services Administration (HRSA) released long-awaited guidance establishing a 340B Rebate Model Pilot Program (Pilot Program). The announcement marks a ...
Widespread and longstanding abuse of a federal program designed to provide prescription drugs to low-income patients has prompted lawmakers in Minnesota and Michigan to try to rein in the 340B program ...
As a rheumatologist practicing in Colorado, my focus is on one thing: delivering the best possible care for my patients. Many who I treat in Colorado Springs are managing complex conditions like gout, ...
On April 28, AEI’s Kirsten Axelsen hosted the former North Carolina Department of Health and Human Services Secretary Kody Kinsley; Anthony DiGiorgio of the University of California, San Francisco; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results